Guardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022
Go back to Guardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 20.29 +2.33 (12.97%) | |||||
---|---|---|---|---|---|---|
Previous Close | $17.96 | 52 Week High | $5.84 | |||
Open | $18.20 | 52 Week Low | $5.49 | |||
Day High | $20.30 | P/E | N/A | |||
Day Low | $18.13 | EPS | $0.00 | |||
Volume | 4,159,097 |